Top 10 stocks in focus today: Sun Pharma, Bharti Airtel, JP Associates, Khadim India
Bharti Airtel offered to sell 3.5 percent stake in Bharti Infratel at Rs 400-415.50 per share.
Sun Pharma subsidiary Taro gets USFDA nod for Fexofenadine Hydrochloride oral suspension.
JP Associates said that the Supreme Court directed the non-institutional directors of infrastucture firm Jaiprakash Associate Ltd (JAL) to appear in person before it next week and furnish details of their personal assets.
Tata Teleservices says total mobile subscribers down 7.3 percent to 6,467 lakh in Oct. from 69.8 lakh in Sept.
Muthoot Capital to issue 27.27 lakh shares at Rs 605 each via QIP.
IOL Chemicals and Pharma to invest Rs 200 crore for expanding manufacturing capacity.
Havells India signed a pact with South Korea’s Hyundai Electric for supply of low and medium voltage protection, and switching devices.
Lupin expects the US drug regulator’s action against the company to leave only an “immaterial dent” on its revenue, even though it would affect its plans to launch new drugs, as per media reports.
JMC Projects gets orders worth Rs 4.51 bn.